HOXC9 and neoplasm: Additionally, with the treatment of PD-1 blockade, concurrent with tumor growth dynamics, the downregulation of Hoxc9 exhibited a pronounced augmentation in CD3+ T cell infiltration, activation of CD8+ T cells, and an upsurge in IFN-γ production (P<0.001).